Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.
Thompson PA, Malogolowkin MH, Furman WL, Piao J, Krailo MD, Chung N, Brock L, Towbin AJ, McCarville EB, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, O'Neill AF, Rodriguez-Galindo C, Meyers RL, Katzenstein HM. Thompson PA, et al. Among authors: katzenstein hm. Pediatr Blood Cancer. 2023 Jul;70(7):e30365. doi: 10.1002/pbc.30365. Epub 2023 Apr 19. Pediatr Blood Cancer. 2023. PMID: 37073741 Free PMC article.
Children's Oncology Group's 2023 blueprint for research: Liver tumors.
O'Neill AF, Meyers RL, Katzenstein HM, Geller JI, Tiao GM, López-Terrada D, Malogolowkin M; Liver Tumor Committee. O'Neill AF, et al. Among authors: katzenstein hm. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30576. doi: 10.1002/pbc.30576. Epub 2023 Jul 26. Pediatr Blood Cancer. 2023. PMID: 37495540 Free PMC article.
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL. Katzenstein HM, et al. J Clin Oncol. 1998 Jun;16(6):2007-17. doi: 10.1200/JCO.1998.16.6.2007. J Clin Oncol. 1998. PMID: 9626197
Angiogenesis in neuroblastoma.
Katzenstein HM, Cohn SL, Crawford S, Meitar D. Katzenstein HM, et al. J Clin Oncol. 2000 Jul;18(14):2789-91. doi: 10.1200/JCO.2000.18.14.2789. J Clin Oncol. 2000. PMID: 10894881 No abstract available.
Antiangiogenic therapy inhibits human neuroblastoma growth.
Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL. Katzenstein HM, et al. Med Pediatr Oncol. 2001 Jan;36(1):190-3. doi: 10.1002/1096-911X(20010101)36:1<190::AID-MPO1045>3.0.CO;2-I. Med Pediatr Oncol. 2001. PMID: 11464880
102 results